I hold a PhD in the field of epidemiology a masters degree in public health. My undergraduate training is in policy, economics and the sciences. I have utilized my training in employment with government, academia, private industry and to further analyze the fundamentals and technicals of all manner of companies in different sectors. Specifically, I like to trade growth companies, REITS, biotechnology/ pharmaceuticals, precious metals, blue chips and small-cap companies.
Each market day I get up at 530 am and begin working/analyzing data before my day job. I focus much on current events, earnings, and developments. I also work after market hours to cover after hours developments or interesting action during the day. I aim to conduct 2 analysis per business day, which helps me stay focused on my own finances.
I have been investing for about 10 years. I also enjoy trading short expiration options, and investing in stocks with 3-20 year horizons. I enjoy writing with Seeking Alpha to share my opinion and analyses. I am a large believer in the crowd source model championed by Seeking Alpha and believe every ounce of analysis and opinion should be considered when you invest your personal finances.
Business owner for over 35 years now working less and investing more. Our company has grown from $1M in sales to $25M in that time. I have recently sold my shares as part of an exit strategy. My philosophy for success in life and business is based on creativity. As Albert Einstein once said, "Insanity: doing the same thing every day and expecting a different result."
I will cover alternative energy, tech and other disruptive firms that have the potential to change or lead in their chosen industry. I utilize a process of thorough fundamental analysis, ensuring I have a solid understanding of the drivers behind not only a specific firm, but the industry as a whole.
To reach out to me with questions, to discuss an article or anything else, please send me a private message through Seeking Alpha.
I am mostly a daytrader engaging in both long and short bets intraday and occasionally over the short to medium term. My focus is mostly on tech stocks and more recently the shipping and offshore drilling industry.
I am located in Germany and have worked many years as an auditor for PricewaterhouseCoopers before becoming a daytrader almost 15 years ago.
During this time I managed to successfully maneuver the burst of the dotcom bubble and the aftermath of the world trade center attacks as well as the subprime crisis.
My return on employed capital has been mostly good and at times reaches up to several 100% annually so I guess I will be around for some more years.
“When you are inspired by some great purpose, some extraordinary project, all your thoughts break their bonds: Your mind transcends limitations, your consciousness expands in every direction, and you find yourself in a new, great and wonderful world. Dormant forces, faculties and talents become alive, and you discover yourself to be a greater person by far than you ever dreamed yourself to be.” (Author - Patanjali)
“Tentative efforts lead to tentative outcomes. Therefore, give yourself fully to your endeavors. Decide to construct your character through excellent actions and determine to pay the price of a worthy goal. The trials you encounter will introduce you to your strengths. Remain steadfast...and one day you will build something that endures: something worthy of your potential.” (Author - Epictetus)
"Hope sees the invisible, feels the intangible, and achieves the impossible." (Author - Unknown)
"When I stand before God at the end of my life, I would hope that I would not have a single bit of talent left, and could say, 'I used everything you gave me." (Author - Erma Bombeck)
Learning as I go. My investing experience is limited, but I believe that biotechnology/pharmaceuticals hold the key to the best returns in the next 5-10 years. Targeted therapy, monoclonal antibodies, and genetic treatment tailoring are the future of medicine.
I am a practicing Army Physician (Diagnostic Radiologist). My professional interests include neuroradiology, brain tumors, head and neck cancer, functional MRI, and emerging tagged imaging agents. I intend to apply for a fellowship in neuroradiology this coming Summer. As such, I intend my writing to be speculative, but directed by science and my experiences thus far in medicine with an optimistic essence.
Full-time investor. Formerly buy-side credit analyst (2yrs) covering Japanese + Asian companies. Before that, I was a cross asset derivatives salesperson at a large bulge-bracket firm, based in Tokyo (4yrs). I use Seeking Alpha to clarify and synthesize my investment thought process and to elicit feedback on my theses; additionally I like to connect with other investors and swap ideas.
You can read my finance-related blog at rapercapital.com (less organized than Seeking Alpha writeups, more my random musings on various finance-related topics).
Going forward I will try to tweet my investment-related thoughts/updates to articles/etc. You can follow me on Twitter, my handle is @puppyeh1
Always looking for new ideas across the board. Happy to exchange ideas/share thoughts/swap notes, feel free to private message me. I currently live in Singapore.
Heath Winter is the Managing Partner of ArbitrOption Capital Management, LLC and is responsible for research, trading, and portfolio management. Prior to forming ArbitrOption, Mr. Winter was Director of Research for the event-driven and special situations strategy of Silverado Capital Management from 2005 until 2009. Mr. Winter’s responsibilities at Silverado included generating investment ideas as well as researching positions and managing the portfolio. In addition, Mr. Winter was employed as an Analyst at M.H. Davidson, LLC in 2003 and as a Merger Arbitrage Analyst at Swidler Berlin Shereff Friedman, LLP from 2000 to 2002. He graduated with an MBA in Finance and Economics from Columbia Business School in 2004 and a BA in International Affairs from The George Washington University in 1997.
Mike Winston, CFA is the founder and Managing Principal of Sutton View Capital LLC, an employee owned hedge fund sponsor and advisor. The firm provides its services to high net worth individuals, family offices and institutions. Sutton View was founded in 2012 and is focused on event-driven and intrinsic value investing.
Mr. Winston received an MBA in Finance and Economics from Columbia Business School in 2005, and a BA in Economics from Cornell University in 1999. At Columbia he completed the school’s program in Value Investing, and while at Cornell studied for a year at the London School of Economics. He began his career in 1999 with Credit Suisse First Boston.
Mr. Winston is a CFA charter holder and a member of the Economic Club of New York.
I am a psychologist at the University of Massachusetts/Amherst. I am on our campus’s Institutional Review Board, which must conclude that proposed studies involving human subjects are conducted ethically and are designed well enough so that any risks involved are justified by the likely benefits obtained.
I teach about analytical reasoning, leadership skills, reconciling apparently incompatible positions, designing, implementing, and evaluating policies, and how to critically evaluate competing health claims based on the samples studied and methods of data collection and analysis used.
Most of my investments involve owning medical industry stocks.
I am a high school teacher for a decade.
Before that I was an analyst (operations and financial) and for a short time a Controller
I have a B.S. with an emphasis in Accounting and an MBA (for which I studied Finance, Economics, and Management)
I passed the CPA exam on the first try and am a retired CPA in the state of Maryland.
I have a high school teaching credential and an MA in Math Education
Jonathan co-founded Booth-Laird Enterprises, LLC in 2007 and serves as the company’s chief executive officer. He is primarily responsible for structuring and overseeing the company’s vision of wealth creation via value-decision making, setting an appropriate culture, and overseeing the company’s investments.
Jonathan is a Chartered Financial Analyst and a Certified Public Accountant. He was awarded the 2006 Elijah Watt Sells award for scoring one of the 10 highest scores in the nation on the 2006 CPA exam. He also passed all three levels of the CFA exam on his first attempt. In addition, he was awarded the 2008 “Top 40 Under Forty” award from the Greater Baton Rouge Business Report, which is given annually to the forty men and women under the age of forty who have earned the most personal and professional achievements or made the most significant impact in the Greater Baton Rouge area.
He worked for three years as an auditor with Ernst & Young, LLP and KPMG, LLP, two of the four largest accounting firms in the world. At both firms, he was rated “exceptional performer” every year and was entrusted with responsibilities above his level within months of starting with each firm. He audited both public and private companies in a variety of industries, including acting as the lead audit senior on a Fortune 500 company. He was regularly assigned the most complex accounting issues and the most challenging audit areas. As a result of his experience, he has developed an astute understanding of risk management, team management, optimal business processes, effective corporate governance practices, and various industries and business models.
While at KPMG, he served as the only South Louisiana member on the KPMG Point-of-View group, an internal group of highly rated employees across the United States focused on strategic initiatives and determining best practices.
Subsequent to KPMG, he worked for a year in Governor Bobby Jindal’s administration as the Assistant Director of State Economic Competitiveness, a subgroup of the Department of Economic Development charged with helping to shape the State’s economic policy in addition to various other tasks. Among a number of other significant projects, he helped craft the department-wide business plan for Fiscal Year 2009-2010, which further developed his strategic planning capabilities. He also met with representatives of the business community to help resolve issues or to hear proposals, which gave him further insight into various industries and business models.
Jonathan earned a bachelor’s of science in accounting from Louisiana State University, graduating summa cum laude, and earned a master of science in accounting from Louisiana State University, graduating top of his class with a perfect 4.0 GPA.
Wall Street Breakfast, Seeking Alpha's flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day's key financial news. It's designed for easy readability on the site or by email (including on mobile devices), and is published before 7:00 AM ET every market day.
Wall Street Breakfast readership of over 900,000 includes many from the investment-banking and fund-management industries.
Sign up here to receive the Wall Street Breakfast in your inbox every business day: http://seekingalpha.com/account/email_preferences
I am an individual investor who has been actively involved in the healthcare and biotechnology space for over 15 years. I hold a PhD in the biomedical sciences and have worked in both large pharmaceutical and small biotech companies. I make investments based on the fundamentals of a company and if I believe they have a superior technology or products compared to the competition. I'm an investor who believes patience pays off.
Investor focused primarily on the Biotech Industry. I look for undervalued companies with strong management, unmet disease state and quality pipeline. I have worked in the biotech industry for many years and have a strong background in science and statistics.
Former US Naval Aviator, now Independent Investor and Trader. I do side work as an in house hedge fund analyst and work with private wealth clients. I am a Finance MBA candidate at Pepperdine University, with an undergraduate degree in Business with Economics emphasis from Purdue University. I scan markets for Oversold and Overbought candidates that provide excellent risk/reward opportunities. I focus mainly on small cap stocks.
CSPT is an independent, student-led investment fund at the University of Chicago. Our portfolio is diversified across various styles of equity and fixed income investing; however, our primary objective is to pursue a deep-value approach to identify underpriced small- and micro-cap equities across a range of regions and industries. To learn more, please visit our website, "csptfund.com".
Please note that even though all members are registered University of Chicago students, our assets are entirely comprised of members' capital commitments, and so we are not officially affiliated with the University of Chicago endowment, administration, or any other relevant representative bodies.
Lowenthal Capital Partners (LCP) has joined Arrow Loop Research to deliver a value-based investing newsletter called Arrow Loop Research's Actionable Ideas for Maximizing Returns. Sign up for a free trial here.
LCP is operated by Trevor Lowenthal. Trevor graduated with a BA in Political Science from University of California, Davis with Summa Cum Laude distinction. Trevor is finishing his J.D. at the University of Colorado Boulder Law School.
Arrow Loop Research formed as a partnership between LCP, Dr. Paul Price, and Market Shadows (Paul is a managing partner of Market Shadows.)
Paul writes about stocks, options and the market every weekday on Real Money Pro, a subscription site on TheStreet.com. Paul has been a speaker at the International Traders Expo in New York City and the Options and Forex Expo in Las Vegas. He also gives investment seminars for subscribers of TheStreet's multiple subscription sites. Dr. Price is a featured contributor on Market Shadows.com, GuruFocus.com and TalkMarkets.com.
Paul followed his passion for the stock market when he gave up his career as a dentist to join Merrill Lynch back in April of 1987. Paul feels that he is “living the dream” of many investors. He stopped “going to work” when he turned 50 (in the year 2000) and has been living well from his investment returns ever since.
Paul enjoys sharing the accumulated market wisdom he’s gained from years in the markets. He loves analyzing companies and picking individual stocks. According to Paul, once you know what equities to buy, option writing (selling covered calls and/or naked puts) just flows naturally. They serve as ways to impose investment discipline and create income while providing an extra margin of safety versus plain vanilla share ownership. Paul’s articles stand out for their unique graphics which are packed with information which distills our TMI (too much information) world into easy to understand, and actionable advice.
Fredrik Arnold is my pen name. In 2012 I retired from doing quality service analysis for John Hancock Long Term Care Insurance in Boston then moved to North Carolina in 2013. My fascination with capital preservation, fixed fractional trading, and trading systems keeps me blogging for Seeking Alpha. Most of my articles focus on dividend yields and analyst mean 1 yr targets as stock trading indicators. These are essential tools for catching the most valuable dividend dogs.
I am an activist investor in US and Chinese stocks. I was previously an investment banker in New York Hong Kong and London for 9 years, focused on Equity Capital Markets. I look at both long ideas and short ideas and typically focus on a small number on names where I can spend the time to conduct very deep research. I spend my time living between Los Angeles and Beijing, China.
I have been an analyst since 1970 and have been following advances in biotech since the 1980's. I see a strong trend toward acceleration of new technologies such as stem cell therapeutics that provide excellent long term investment vehicles. I believe new technologies in well positioned small cap companies offer the ideal risk to reward ratios and the best opportunities to accumulate wealth. I have learned over the years that every investment comes with risk and the key to success is identifying the risk, managing that risk, and knowing when to exit because new technologies can be so disruptive.
I'm an independent equity researcher, writer and investor based in Amsterdam. My primary focus is on the micro-cap segment of the market. I also work for pension funds as a member of the Board and Investment Committee. Lastly, I enjoy soccer, sports in general and brewing the best coffee one can make at home.
Saj Karsan founded an investment and research firm that is based on the principles of value investing. He has an MBA from the Richard Ivey School of Business, has completed all three CFA exams, and has an engineering degree from McGill University. Visit his blog, Barel Karsan (http://barelkarsan.com/).
I have written 2 dutch books on value investing: "Aandelen selecteren als waardebelegger" and "Beleggen in bull- en bearmarkten". See bol.com (search for the titles). As a mathematician (Ph.D.) I am most interested in investment strategies with statistically favorable returns. In particular I invest in net-nets (20-30% average annual returns). I find companies with low Enterprise Value/Earnings before Tax and Interest (EV/EBIT) and strong balance sheets (20% average annual returns) also very interesting. Since such stocks are rare I invest globally. Send me a message with your email address to get example articles of my premium research on Seeking Alpha.
Portfolio manager delivering alpha principally through the discovery of under-the-radar small cap names with compelling stories misunderstood/underappreciated by the market.
Holmes Osborne has been principal of Osborne Global Investments since 2004. Holmes holds the Chartered Financial Analyst designation and a degree in finance from Syracuse University. He has been featured three times in the Wall Street Journal and once in Fortune Magazine and Investors' Business Daily. Holmes has written financial columns for Seeking Alpha, the Motley Fool, and theStreet.com. Client assets are held at Charles Schwab. He lives with his wife Jennifer and daughters Adelaide and Emily.